LTL331 xenografts exhibiting a classic prostate adenocarcinoma phenotype were transformed into castration‐resistant NEPC LTL331R tumours, during which Wnt9A and Wnt4 was markedly upregulated (Figure 8F). Here, WNT9A is linked to prostate adenocarcinoma.